This is likely attributable to underlying disease biology and prevention of end-organ damage by early treatment initiation, as benefit was independent...
We find that patients with CTCL are at increased risk of second malignancies, especially Hodgkin and non-Hodgkin lymphoma, lung cancer, bladder cancer...
The prevalence of lymphoma reported in sarcoidosis patients is higher than the general population which further supports the possible increased risk...